UK Smooths Clinical Trial Pathway To Reassure Companies With Brexit Jitters

The UK is revising its clinical trial processes to align them with the new EU Clinical Trials Regulation so that companies can seek authorization just as easily in the UK as in other EU member states, irrespective of the situation after Brexit.

EU_UK
UK Is On Track To Adopt EU's Clinical Trial Package Irrespective Of Brexit • Source: Shutterstock

More from Clinical Trials

More from R&D